FDA 483 data is just the tip of the iceberg
AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

EIR GlaxoSmithKline Biologicals SA, Feb 2000

$595 - Available for instant download

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observations (via FDA 483) on 25 Feb 2000.

Product Details

  • Category: Biologics
  • Inspection end: 25 Feb 2000
  • Location: Rixensart, Belgium
  • FEI: 3002875226
GlaxoSmithKline Biologicals SA FDA inspection 483 Feb 2000

Related Products